Possible involvement of oxidative stress in salivary gland of patients with Sjögren's syndrome

Pathobiology

Volumn 73, Issue 5, 2007, Pages 252-260

  Ryo, Koufuchi ^a   Yamada, Hiroyuki ^a   Nakagawa, Yoichi ^a   Tai, Yoshinori ^a   Obara, Kumi ^a   Inoue, Hiroko ^a   Mishima, Kenji ^a   Saito, Ichiro ^a  

^a TSURUMI UNIVERSITY   (Japan)

Author keywords

Autoimmunity; Oxidative stress; Saliva; Salivary gland

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; HEXANOYLLYSINE; LACTATE DEHYDROGENASE; LYSINE DERIVATIVE; MITOCHONDRIAL ENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNITY; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; OXIDATIVE STRESS; PRIORITY JOURNAL; SALIVA; SALIVARY GLAND; SALIVARY GLAND DISEASE; SJOEGREN SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; ASPARTATE AMINOTRANSFERASES; DEOXYGUANOSINE; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MIDDLE AGED; MITOCHONDRIA; OXIDATIVE STRESS; SALIVA; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 33847416556     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098211     Document Type: Article

References (56)

1. Fox RI: Sjogren's syndrome. Lancet 2005;366:321-331.
2. Bell DA, Maddison PJ: Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 1980;23:1268-1273.
3. Mann DL, Moutsopoulos HM: HLA DR alloantigens in different subsets of patients with Sjogren's syndrome and in family members. Ann Rheum Dis 1983;42:533-536.
4. Manthorpe R, Teppo AM, Bendixen G, Wegelius O: Antibodies to SS-B in chronic inflammatory connective tissue diseases. Relationship with HLA-Dw2 and HLA-Dw3 antigens in primary Sjogren's syndrome. Arthritis Rheum 1982;25:662-667.
5. Buttke TM, Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10.
6. Jacobson MD: Reactive oxygen species and programmed cell death. Trends Biochem Sci 1996;21:83-86.
7. Holmgren A: Thioredoxin. Annu Rev Biochem 1985;54:237-271.
8. Nakamura H, Nakamura K, Yodoi J: Redox regulation of cellular activation. Annu Rev Immunol 1997;15:351-369.
9. Mayer M, Noble M: N-Acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 1994;91:7496-7500.
10. Cossarizza A, Franceschi C, Monti D, Salvioli S, Bellesia E, Rivabene R, Biondo L, Rainaldi G, Tinari A, Malorni W: Protective effect of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: the role of mitochondria. Exp Cell Res 1995;220:232-240.
11. Saito I, Shimuta M, Terauchi K, Tsubota K, Yodoi J, Miyasaka N: Increased expression of human thioredoxin/adult T cell leukemia-derived factor in Sjogren's syndrome. Arthritis Rheum 1996;39:773-782.
12. Bashir S, Harris G, Denman MA, Blake DR, Winyard PG: Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis 1993;52:659-666.
13. Miyata T, Ishiguro N, Yasuda Y, Ito T, Nangaku M, Iwata H, Kurokawa K: Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem Biophys Res Commun 1998;244:45-49.
14. Mantle D, Falkous G, Walker D: Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clin Chim Acta 1999;284:45-58.
15. Ozkan Y, Yardym-Akaydyn S, Sepici A, Keskin E, Sepici V, Simsek B: Oxidative status in rheumatoid arthritis. Clin Rheumatol, in press.
16. Baskol G, Demir H, Baskol M, Kilic E, Ates F, Karakukcu C, Ustdal M: Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Funct 2006;24:307-311.
17. Jikimoto T, Nishikubo Y, Koshiba M, Kanagawa S, Morinobu S, Morinobu A, Saura R, Mizuno K, Kondo S, Toyokuni S, Nakamura H, Yodoi J, Kumagai S: Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 2002;38:765-772.
18. Rall LC, Roubenoff R, Meydani SN, Han SN, Meydani M: Urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) as a marker of oxidative stress in rheumatoid arthritis and aging: effect of progressive resistance training. J Nutr Biochem 2000;11:581-584.
19. Reznick AZ, Shehadeh N, Shafir Y, Nagler RM: Free radicals related effects and antioxidants in saliva and serum of adolescents with type 1 diabetes mellitus. Arch Oral Biol 2006;51:640-648.
20. Hata I, Kaji M, Hirano S, Shigematsu Y, Tsukahara H, Mayumi M: Urinary oxidative stress markers in young patients with type 1 diabetes. Pediatr Int 2006;48:58-61.
21. Saito I, Servenius B, Compton T, Fox RI: Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med 1989;169:2191-2198.
22. Inoue H, Tsubota K, Ono M, Kizu Y, Mizuno F, Takada K, Yamada K, Yanagi K, Hayashi Y, Saito I: Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome. J Immunol 2001;166:5801-5809.
23. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y: Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science 1997;276:604-607.
24. Halliwell B, Aruoma OI: DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 1991;281:9-19.
25. Kasai H, Crain PF, Kuchino Y, Nishimura S, Ootsuyama A, Tanooka H: Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 1986;7:1849-1851.
26. Cooke MS, Evans MD, Lunec J: DNA repair: insights from urinary lesion analysis. Free Radic Res 2002;36:929-932.
27. Shigenaga MK, Gimeno CJ, Ames BN: Urinary 8-hydroxy-2′- deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 1989;86:9697-9701.
28. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444-445.
29. Takane M, Sugano N, Iwasaki H, Iwano Y, Shimizu N, Ito K: New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals. J Periodontol 2002;73:551-554.
30. Tsukahara H, Sekine K, Uchiyama M, Kawakami H, Hata I, Todoroki Y, Hiraoka M, Kaji M, Yorifuji T, Momoi T, Yoshihara K, Beppu M, Mayumi M: Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatr Res 2003;54:419-424.
31. Kato Y, Mori Y, Makino Y, Morimitsu Y, Hiroi S, Ishikawa T, Osawa T: Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 1999;274:20406-20414.
32. Fox RI, Saito I: Criteria for diagnosis of Sjogren's syndrome. Rheum Dis Clin North Am 1994;20:391-407.
33. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T: Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997;76:365-374.
34. Saito S, Yamauchi H, Hasui Y, Kurashige J, Ochi H, Yoshida K: Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA. Res Commun Mol Pathol Pharmacol 2000;107:39-44.
35. Greenspan JS, Daniels TE, Talal N, Sylvester RA: The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974;37:217-229.
36. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558.
37. Kregel KC, Zhang HJ: An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 2007;292:R18-R36.
38. Hahm KB, Lee KJ, Kim JH, Cho SW, Chung MH: Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide. Dig Dis Sci 1998;43:72S-77S.
39. Romano G, Sgambato A, Mancini R, Capelli G, Giovagnoli MR, Flamini G, Boninsegna A, Vecchione A, Cittadini A: 8-Hydroxy-2′-deoxyguanosine in cervical cells: correlation with grade of dysplasia and human papillomavirus infection. Carcinogenesis 2000;21:1143-1147.
40. Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F: Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjogren's syndrome. Am J Med 1991;90:286-294.
41. Saito I, Nishimura S, Kudo I, Fox RI, Moro I: Detection of Epstein-Barr virus and human herpes virus type 6 in saliva from patients with lymphoproliferative diseases by the polymerase chain reaction. Arch Oral Biol 1991;36:779-784.
42. Fox RI, Pearson G, Vaughan JH: Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J Immunol 1986;137:3162-3168.
43. Fox RI, Bumol T, Fantozzi R, Bone R, Schreiber R: Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjogren's syndrome. Arthritis Rheum 1986;29:1105-1111.
44. Tateishi M, Saito I, Yamamoto K, Miyasaka N: Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjogren's syndrome. Possible involvement of a novel strain of Epstein-Barr virus in disease pathogenesis. Arthritis Rheum 1993;36:827-835.
45. Sullivan JL: Epstein-Barr virus and lymphoproliferative disorders. Semin Hematol 1988;25:269-279.
46. Inoue N, Harada S, Miyasaka N, Oya A, Yanagi K: Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjogren's syndrome and with rheumatoid arthritis. J Infect Dis 1991;164:22-28.
47. Yamaoka K, Miyasaka N, Yamamoto K: Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjogren's syndrome. Arthritis Rheum 1988;31:1014-1021.
48. Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Pope JH: Long-term T-cell-mediated immunity to Epstein-Barr virus. Cancer Res 1981;41:4216-4221.
49. Slaughter L, Carson DA, Jensen FC, Holbrook TL, Vaughan JH: In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med 1978;148:1429-1434.
50. Cerimele F, Battle T, Lynch R, Frank DA, Murad E, Cohen C, Macaron N, Sixbey J, Smith K, Watnick RS, Eliopoulos A, Shehata B, Arbiser JL: Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc Natl Acad Sci USA 2005;102:175-179.
51. Yoshimasu T, Hiroi A, Ohtani T, Uede K, Furukawa F: Comparison of anti 60 and 52 kDa SS-A/Ro antibodies in the pathogenesis of cutaneous lupus erythematosus. J Dermatol Sci 2002;29:35-41.
52. Saegusa J, Kawano S, Koshiba M, Hayashi N, Kosaka H, Funasaka Y, Kumagai S: Oxidative stress mediates cell surface expression of SS-A/Ro antigen on keratinocytes. Free Radic Biol Med 2002;32:1006-1016.
53. Krapfenbauer K, Birnbacher R, Vierhapper H, Herkner K, Kampel D, Lubec G: Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus. Clin Sci (Lond) 1998;95:331-337.
54. Erhola M, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Uchida K, Osawa T, Nieminen MM, Alho H, Kellokumpu-Lehtinen P: Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2′- deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett 1997;409:287-291.
55. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K: Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002;346:1954-1962.
56. Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, Poulsen HE: Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992;13:2241-2247.